Dalbavancin

ATC J01XA04 · 6 markets · 23 records

Dalbavancin 6 markets · 23 records Forms

US 7 records · 2 strengths

500 mginjectionDalbavancin also in ES·GB
500 mg/25 mLinjectionDALVANCE+5Manufacturer: BE Pharmaceuticals Inc.、Manufacturer: Fresenius Kabi USA, LLC、Manufacturer: Meitheal Pharmaceuticals Inc、Manufacturer: Somerset Therapeutics, LLC、Manufacturer: Teva Pharmaceuticals, Inc.

ES 6 records · 1 strengths

500 mginjectionDALBAVANCINA ACCORD+5DALBAVANCINA ADVANZ PHARMA、DALBAVANCINA REDDYS、DALBAVANCINA SALA、DALBAVANCINA ZENTIVA、XYDALBA also in US·GB

GB 4 records · 1 strengths

500 mginjectionDalbavancin 500mg powder for concentrate for solution for infusion vials+1Xydalba 500mg powder for concentrate for solution for infusion vials also in US·ES

CA 1 records · 1 strengths

500 mgpowderXYDALBA

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名XYDALBA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 strengths

516 mginjectionXYDALBA 500 mg, poudre pour solution à diluer pour perfusion

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.